↓ Skip to main content

Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, March 2015
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
39 Mendeley